Tectonic Therapeutic, Inc. (TECX)
31.22
+1.28
(+4.28%)
USD |
NASDAQ |
Sep 01, 16:00
Tectonic Therapeutic 1 Year Total Returns (Daily) : 22.24% for Sept. 1, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 01, 2026 | 22.24% |
| August 31, 2026 | 17.23% |
| August 28, 2026 | 39.30% |
| August 27, 2026 | 38.18% |
| August 26, 2026 | 40.02% |
| August 25, 2026 | 53.48% |
| August 24, 2026 | 39.30% |
| August 21, 2026 | 48.18% |
| August 20, 2026 | 49.71% |
| August 19, 2026 | 56.29% |
| August 18, 2026 | 48.16% |
| August 17, 2026 | 43.98% |
| August 14, 2026 | 42.66% |
| August 13, 2026 | 53.83% |
| August 12, 2026 | 68.33% |
| August 11, 2026 | 44.14% |
| August 10, 2026 | 46.62% |
| August 07, 2026 | 41.33% |
| August 06, 2026 | 30.48% |
| August 05, 2026 | 31.20% |
| August 04, 2026 | 37.85% |
| August 03, 2026 | 34.68% |
| July 31, 2026 | 26.32% |
| July 30, 2026 | 26.60% |
| July 29, 2026 | 27.43% |
| Date | Value |
|---|---|
| July 28, 2026 | 31.08% |
| July 27, 2026 | 37.14% |
| July 24, 2026 | 36.31% |
| July 23, 2026 | 37.91% |
| July 22, 2026 | 42.17% |
| July 21, 2026 | 49.64% |
| July 20, 2026 | 46.37% |
| July 17, 2026 | 40.03% |
| July 16, 2026 | 35.80% |
| July 15, 2026 | 51.59% |
| July 14, 2026 | 50.56% |
| July 13, 2026 | 51.71% |
| July 10, 2026 | 58.24% |
| July 09, 2026 | 63.67% |
| July 08, 2026 | 72.15% |
| July 07, 2026 | 75.82% |
| July 06, 2026 | 65.04% |
| July 02, 2026 | 79.85% |
| July 01, 2026 | 62.40% |
| June 30, 2026 | 73.00% |
| June 29, 2026 | 67.12% |
| June 26, 2026 | 59.43% |
| June 25, 2026 | 52.48% |
| June 24, 2026 | 52.31% |
| June 23, 2026 | 63.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 11.16% |
| Alnylam Pharmaceuticals, Inc. | -44.88% |
| Anika Therapeutics, Inc. | 125.1% |
| Savara, Inc. | 63.11% |
| Vericel Corp. | 11.39% |